Xarelto was approved in 2011 as a blood thinner. It is manufactured by Bayer, a subsidiary of Johnson & Johnson, and brings in about $2 billion annually. Xarelto is used to prevent blood clots and strokes in patients who have deep vein thrombosis, pulmonary embolism, and atrial fibrillation.
However, Xarelto has been shown to cause uncontrollable bleeding that can be very dangerous. Unlike other blood thinners, there is no antidote available to reverse the effects of the drug and stop the bleeding. Unfortunately, Bayer and Johnson & Johnson never warned patients about the risks of the drug.
Warfarin is the biggest competitor to Xarelto. Warfarin is a blood thinning medication introduced in the 1950’s. Warfarin requires regular blood monitoring in order to be safe and effective. One highly-touted advantage of Xarelto is that, unlike Warfarin, Xarelto does not require that regular blood monitoring. Another difference is that Warfarin has an antidote, Vitamin K, which can be administered to patients who are bleeding too much. Xarelto has no such antidote.
Some of the side effects of Xarelto are fairly minor, including nosebleeds, bleeding gums, and headaches. However, there are major side effects to Xarelto, which can be more worrisome, including vomiting blood, heavy nosebleeds, swelling, strange bruising, severe headaches, and vision changes.
If you have been taking Xarelto, and you believe that you suffered injuries as a result of taking the drug, we will provide you with a free consultation on our case.